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Abstract - Purpose: Application of low intensity electric fields to interfere with tumor growth
is being increasingly recognized as a promising new cancer treatment modality. Intratumoral
modulation therapy (IMT) is a developing technology that uses multiple electrodes implanted
within or adjacent tumor regions to deliver electric fields to treat cancer. In this study, the
determination of optimal IMT parameters was cast as a mathematical optimization problem, and
electrode configurations, programming, optimization, and maximum treatable tumor size were
evaluated in the simplest and easiest to understand spherical tumor model. The establishment of
electrode placement and programming rules to maximize electric field tumor coverage designed
specifically for IMT is the first step in developing an effective IMT treatment planning system.
Methods: Finite element method electric field computer simulations for tumor models with 2 to 7
implanted electrodes were performed to quantify the electric field over time with various
parameters, including number of electrodes (2 to 7), number of contacts per electrode (1 to 3),
location within tumor volume, and input waveform with relative phase shift between 0 and 2𝜋
radians. Homogeneous tissue specific conductivity and dielectric values were assigned to the
spherical tumor and surrounding tissue volume. In order to achieve the goal of covering the tumor
volume with a uniform threshold of 1 V/cm electric field, a custom least square objective function
was used to maximize the tumor volume covered by 1 V/cm time averaged field, while maximizing
the electric field in voxels receiving less than this threshold. An additional term in the objective
function was investigated with a weighted tissue sparing term, to minimize the field to surrounding
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tissues. The positions of the electrodes were also optimized to maximize target coverage with the
fewest number of electrodes. The complexity of this optimization problem including its nonconvexity, the presence of many local minima, and the computational load associated with these
stochastic based optimizations led to the use of a custom pattern search algorithm. Optimization
parameters were bounded between 0 and 2𝜋 radians for phase shift, and anywhere within the tumor
volume for location. The robustness of the pattern search method was then evaluated with 50
random initial parameter values.
Results: The optimization algorithm was successfully implemented, and for 2 to 4 electrodes,
equally spaced relative phase shifts and electrodes placed equidistant from each other was optimal.
For 5 electrodes, up to 2.5 cm diameter tumors with 2.0 V, and 4.1 cm with 4.0 V could be treated
with the optimal configuration of a centrally placed electrode and 4 surrounding electrodes. The
use of 7 electrodes allow for 3.4 cm diameter coverage at 2.0 V and 5.5 cm at 4.0 V. The evaluation
of the optimization method using 50 random initial parameter values found the method to be robust
in finding the optimal solution.
Conclusions: This study has established a robust optimization method for temporally optimizing
electric field tumor coverage for IMT, with the adaptability to optimize a variety of parameters
including geometrical and relative phase shift configurations.

Keywords - Optimization, Pattern Search Method, Electric Field, Tumor, Electrotherapy,
Computer Simulation
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Introduction

There have been substantial recent advances in the application of electric fields to treat
various forms of cancer1-12. Intratumoral modulation therapy (IMT) is a developing technology
that uses implanted bioelectrodes to generate electric fields to control tumor growth10-12. By
implanting electrodes directly within or adjacent the tumor volume, IMT has the potential to
provide perpetual, titratable therapy for a variety of tumor types using a concealed, low
maintenance delivery system. Preclinical studies in malignant brain tumors have demonstrated
robust efficacy of IMT monotherapy at 200 kHz, +/- 2 V stimulation through in vitro investigations
of patient derived Glioblastoma Multiforme (GBM) cells (65% cell viability)11, and in vivo rodent
models (20% reduction in tumor volume)11. While there is currently no observed impact on normal
neurons or adverse neurological effects in the treated rodent cohort for low voltage (2 V),
intermediate frequency (200 kHz) electric fields11-12, surgical implantation of electrodes will pose
the main safety concern with this treatment on human patients. A marked benefit of incorporating
IMT within multi-modality treatment paradigms was observed through in vitro GBM models (cell
viability reduction from 83% for temozolomide (TMZ) alone to 46% for combined IMT+TMZ)11,
and on patient derived diffuse intrinsic pontine glioma cells, where incorporating IMT with
combined radiation and TMZ (44% vs. 60% cell viability) reduced cell viability to 20%10. These
studies were performed however using a non-optimized single electrode system with no phase
shifting of input waveforms that was subsequently found to be limited by inadequate spatial
coverage, with only 6.2% of the in vitro dish area covered by the desired 1 V/cm10 and associated
constraints on tumor control with 24% of an in vivo tumor receiving 1 V/cm11.
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An extensive search of the published literature through databases including PubMed,
Google Scholar and Scopus was completed using Boolean OR keywords such as tumor treating
fields computer simulations and optimizations, implantable electrotherapeutic devices, deep brain
stimulation, electroporation, electric field optimization, simulation-based optimization and nonconvex optimization. There are publications on optimizing electric field for treatment of tumors
from external devices7-9,13,14-16, for deep brain stimulation with multiple contacts to steer the field
to treat the intended millimeter sized target17, and for electroporation with multiple electrodes to
cover tumor volumes with large field magnitude18-19. The present study is the first of its kind to
extend and optimize the distribution of therapeutic-range IMT fields across tumor volumes using
multiple implanted electrodes rather than a single stimulation source. Advantages of the present
study include incorporating multiple electrodes with multiple contacts, phase shift of input
waveforms, tissue sparing, algorithm robustness evaluation, and avoidance of local minima
through a custom pattern search approach. Critical fundamental unknowns include the maximum
tumor volumes attainable with multi-electrode IMT, configuration and placement of electrodes
and selection of stimulation parameters to maintain a minimal stimulation voltage and number of
electrodes, while still covering the tumor volume with the necessary electric field. Simulations in
previous studies have found that single electrode stimulation only covers a small volume in both
in vitro and in vivo experiments, and multiple electrodes would be required for necessary
coverage10,11. 1 V/cm has been used as a threshold for in vitro4,5,10,11, in vivo4,5,11, and in
Glioblastoma Multiforme clinical trials1-4,20. While it has been suggested that thresholds likely
differ between tumor types10, this study will use a threshold of 1 V/cm to demonstrate our
optimization algorithm. However, the optimization method introduced in this study can use any
desired field threshold. Simulations and optimizations have been established for an external
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device, but electric fields delivered using the external device require an accurate anisotropic
conductivity whole brain map to determine the field to the tumor volume21-22. Conversely,
electrodes placed internally within the tumor volume don’t require the same accuracy of
surrounding tissue conductivity anisotropies, as electric fields are not passing through layers of
tissue with varying electrical properties.
As with early brachytherapy, a set of interstitial implant rules such as the Manchester
system were established to serve as practical treatment planning guidelines for treating tumors of
various sizes23. Both brachytherapy and IMT utilize multiple implanted sources (radiation vs.
electric field) to deliver treatment, with large and steep “dose” gradients near the contact surface,
so the experience gained from early brachytherapy treatment planning in terms of implant rules
can be borrowed to initiate a set of rules for IMT. Providing analogous IMT rules in the present
study for the number of electrodes required to cover various tumor sizes, the placement and
programming of those electrodes, and starting points for patient specific treatment optimization
will allow for clinical implementation of IMT.
Based on experience from external delivery of tumor treating fields7-9,13,14-16, deep brain
stimulation optimizations17, and irreversible electroporation optimizations18-19, the incorporation
of simulations and electric field optimizations ensure the desired field is being delivered to the
tumor volume. The creation of methods to robustly optimize the electric field delivered to a tumor
volume is a necessary step in the development of multi-electrode IMT. Stochastic optimization
algorithms are designed to escape local minima by giving a finite probability to choose
optimization parameters that steps away from the local minimum. Methods to evaluate the
robustness of our algorithm have been considered in this study. We need to determine the
configurations and stimulation parameters that result in the desired electric fields before
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proceeding to performing experiments in vitro and in vivo. In this study we propose the
introduction of multiple stimulating electrodes with relative phase shifts between their respective
stimulation waveforms, as a variable parameter to increase the electric field coverage over time.
We demonstrate that the optimization of treatment parameters can be cast as a mathematical
optimization problem, utilizing computer simulations to compute the electric field distribution
over time. The goal of this study is to determine the optimal geometric electrode configurations
and input waveform relative phase shifts, and to estimate the maximum treatable tumor volume
for between 2 and 7 electrodes. To achieve this, we developed optimization methods that were
utilized to form multi-electrode IMT configuration and programming rules for between 2 and 7
electrodes, to enable future applications to in vitro and in vivo preclinical models and patient
specific human tumor scenarios.

Materials and Methods

A. Electric Field Simulation
The in silico tumor and electrode models were created in COMSOL Multiphysics (v5.4).
Material properties were assigned to each geometrical entity in the model, including tumor,
electrodes, and surrounding media. The optimization procedure in the present study does not
depend on tumor site/location, though we require the electrical properties of the tumor and
surrounding tissue. Since the electrical properties in the brain are most well known, these
simulations were completed using human brain and tumor tissue as an example. A literature search
of measured electrical properties of human brain and tumor tissues at 200 kHz was performed, and
standard relative dielectric 𝜀 and conductivity 𝜎 values for external tumor treating fields simulation
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and treatment planning were used7-9,14-15,22, originally obtained from in vivo measurements on
living tissues at comparable frequencies between 50 and 100 kHz24-27. The relative dielectric and
conductivity values for the tumor were 2000 and 0.24 S/m respectively, and for the normal
surrounding grey matter brain, 3000 and 0.25 S/m7-9,14-15,22,24-27. White matter and grey matter can
be incorporated as needed, since surrounding brain tissue depends on the tumor location. These
conductivity and dielectric values were used to demonstrate the methods, but the pipeline allows
users to input any necessary electrical properties. The example electrode material used here was
platinum-iridium with a relative permittivity of 1

28

and conductivity of 5.278×106 S/m29. The

electrodes were assigned a 0.8 mm radius to represent the upper range in deep brain stimulation
electrode size30-33, with variable contact height to allow for adequate depth coverage, location in
polar coordinates (𝑟, 𝜃), and input voltage sinusoidal waveforms (𝐴 sin(2𝜋𝑓𝑡 − 𝜑)), where 𝐴 is
the amplitude, 𝑓 is the frequency of 200 kHz, 𝑡 is the time, and 𝜑 is the phase shift. Non-ablative
input voltage amplitudes of 2 and 4 V were applied in this study.
The tumor volume was given a variable diameter to allow for the computation of maximum
tumor size versus number of electrodes. The total electrode contact height used was the tumor
diameter + 2 mm, to ensure adequate coverage at the poles, and for multiple contact electrodes,
the spacing between contacts was 0.5 mm30-33. The height of exposed electrode contact is held
constant between single, dual and three contact models. Starting with 2 single contact electrodes,
the number of electrodes was increased to 3, 4, 5, 6 and 7, and the number of contacts per electrode
was also increased to 2 and 3 to further demonstrate our optimization algorithm in 3 dimensions
(Fig. 1).
Using the AC/DC module in COMSOL Multiphysics, each electrode contact was given a
separately programmed input voltage waveform terminal boundary. Any spacing between multiple
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contacts was insulated, satisfying 𝐧 ⋅ 𝐉 = 0 where 𝐧 is the normal vector on the boundary, and 𝐉
is the current density. Electrical insulation was also assumed on the outer boundary of the
surrounding material. On internal boundaries between media with different electrical properties,
continuity is maintained by the boundary condition 𝐧𝟐 ⋅ (𝐉𝟏 − 𝐉𝟐 ) = 0, where subscripts 1 and 2
indicate the different media. A free tetrahedral mesh was created for the model, with varying sizes
depending on the volume material. A time-dependent study was used to compute the electric field
at 16 time points over half a period of the sinusoidal waveform. Using the electric currents user
interface in COMSOL, a finite-element method was used to compute the electric field distribution
on mesh points for our model. The governing equations for the finite element computation are
Ohm’s law (1), the equation of continuity (2), and Gauss’ law (3):

𝐉(𝐱, 𝑡) = 𝜎𝐄(𝐱, 𝑡)

$%(𝐱,))
$)

+ ∇ ⋅ 𝐉(𝐱, 𝑡) = 0

∇ ⋅ 𝜀𝐄(𝐱, 𝑡) = 𝜌(𝐱, 𝑡)

(1)

(2)

(3)

where 𝐉(𝐱, 𝑡) is the current density as a function of location 𝐱 and time 𝑡, 𝜎 is the conductivity,
𝐄(𝐱, 𝑡) is the location and time dependent electric field, 𝜌(𝐱, 𝑡) is the charge density and 𝜀 is the
dielectric constant.
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B. Sensitivity Analysis
In the present models of constant voltage stimulation, the impedance magnitude |𝐙| of the
tissue,

+ -

|𝐙| = ?@ A + (2𝜋𝑓𝐶)- C
,

./.1

(4)

depends on resistance 𝑅 ∝ 1/𝜎 , frequency 𝑓 and capacitance 𝐶 ∝ 𝜀 . COMSOL was used to
simulate the resistance and capacitance, and therefore impedance of the spherical tumor models.
Depending on the number of electrodes, contacts and the geometrical configuration of each model,
the resistance ranged from 100-400 Ω, and the capacitance was ~10-10 F. Based on the maximum
simulated resistance of 400 Ω, and the capacitance of 10-10 F, the impedance was calculated (Eqn.
4) for a range of frequencies from 0 to 4 MHz. The resistance term of the impedance (𝑅.- )
dominated the capacitance term (2𝜋𝑓𝐶)2 up to 2 MHz (𝑅.+ > 2𝜋𝑓𝐶). Above 2 MHz, the
capacitance term dominated (𝑅.+ < 2𝜋𝑓𝐶). For the frequency range in this study (200 kHz), the
resistance and therefore conductivity dominate the impedance. The sensitivity of the impedance to
changes in frequency was examined from 0 to 4 MHz.
To examine the sensitivity of electric field distributions to changes in frequency, the
electric field was simulated for the most complex 5 electrode geometry for a range of frequencies
between 0 and 4 MHz. For each frequency, the resultant electric field matrices for 16 time points
were averaged to obtain the temporal electric field magnitude 𝐸. The relative difference 𝐸2344 in
the temporal average electric field magnitude 𝐸 was calculated relative to the field map at the
reference frequency 𝑓564 of 200 kHz.
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𝐸2344 =

78(4). 894!"# :7

(5)

894!"# :

Temporal average electric field maps were considered equivalent when 𝐸2344 was less than
1%. The sensitivity of electric field to changes in tumor conductivities were also analyzed (Eqn.
5), with 𝑓 and 𝑓564 in (Eqn. 5) replaced with 𝜎 and 𝜎564 . Conductivities between 0.01 and 1 S/m
were analyzed. The relative dielectric constant sensitivity was analyzed with 𝑓 and 𝑓564 in (Eqn.
5) replaced with and 𝜀 and 𝜀564 respectively for dielectrics ranging from 10 to 5000.

C. Optimization Algorithm
The optimization of the electric field coverage was coded in MATLAB and the COMSOL
MATLAB Livelink used to connect our COMSOL model to our MATLAB code. We used the
following least square objective function:

𝐹=

+
;$

-

∑> ΘN𝐸<56= − 𝐸> O N𝐸> − 𝐸<56= O

(6)

where the sum is over the voxel 𝑗, 𝑁= is the number of voxels in the tumor volume, Θ is the
Heaviside function, 𝐸<56= is the prescription electric field threshold, and 𝐸> is the time average
electric field magnitude,

𝐸> =

+
;%

∑3 𝐸3,>

(7)
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where the sum is over time point 𝑖, and 𝑁) is the number of time points. This objective has been
repurposed from radiotherapy34 to be used specifically for IMT delivery, and when minimized,
optimizes the electric field coverage of the tumor over time. The Heaviside function was chosen
to distinguish between covered voxels N𝐸> ≥ 𝐸<56= O and uncovered voxels N𝐸> < 𝐸<56= O, and the
square difference term accounts for the contribution of uncovered voxels. The farther away a voxel
is from the prescription field, the more it will affect the objective. Depending on tumor type, this
prescription field can be changed to any necessary field magnitude. While externally delivered
electric field optimizations typically maximize the average field to the tumor due to the inherently
homogeneous nature of external delivery9,33, the nature of implanted electrodes, where the large
electric fields and steep field gradients present near the electrode contact surface dominate the
electric field average. While the average electric field to the tumor could be maximized using such
objective functions, this could result in areas of the tumor not being covered by the desired field
threshold in the case of implanted electrodes. Similar to brachytherapy, where a target volume is
optimized to be covered by the prescription dose23, we chose an objective function to allow
optimization of the extent of tumor coverage with a more homogeneous electric field distribution
to minimize cold spots34,35.
The algorithm includes an option to minimize the field delivered to regions outside the
tumor volume, by adding a weighted term to the objective function,

𝐺=

+
;$

-

+

-

∑> ΘN𝐸<56= − 𝐸> O N𝐸> − 𝐸<56= O + 𝑤 ∑?N𝐸𝑆? O
;
&

(8)

where w is the weighting factor, the second sum is over the normal tissue voxel 𝑘, 𝑁@ is the number
of voxels in the surrounding normal tissue, and 𝐸𝑆? is the time average electric field magnitude of
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normal tissue voxels. The weighting factor w can be adjusted based on the importance of tissue
sparing, and in this example a weighting factor of 0.1 was chosen based on trial optimizations (w
ranging from 0.05 to 1.00) to balance tumor coverage with the avoidance of critical tissue35. In
addition to incorporating tissue sparing, weighted terms can be added to account for different
tumor regions requiring different field thresholds depending on growth activity.
The optimization parameters used in this study were the location of each electrode (𝑟, 𝜃)
(bounded to within tumor volume), and the phase shift 𝜑 (0 to 2𝜋 radians) of each electrode
contacts input waveform. Models with between 2 and 7 electrodes with 1 to 3 contacts per
electrode were investigated on spherical tumors up to 5.5 cm in diameter. The number of variables
depends on the number of electrodes, and the number of contacts per electrode. In the present
study, we held one electrode angle 𝜃 and one contact phase 𝜑 constant at 0 as the reference.
Therefore, if 𝑛 is the number of electrodes and 𝑐 is the number of contacts, a full parameter
optimization contains 2𝑛 + 𝑛𝑐 − 2 variables.
For each iteration of variables in the optimization algorithm, the electric field over time
was computed in COMSOL, and the resultant field was linearly interpolated on a 100×100×100
grid of equally spaced points covering the tumor volume. As our first step, we employed only
electric field values within the tumor volume in the evaluation of the objective function.
To determine which optimization strategy would best fit this problem, we first determined
whether our objective function was convex36. A function 𝐹 is convex if for all points in the domain
(𝑥⃗, 𝑦⃗) ∈ ℝ@ and all 𝜆 ∈ [0,1]:

𝐹(𝜆𝑥⃗ + (1 − 𝜆)𝑦⃗) ≤ 𝜆𝐹(𝑥⃗) + (1 − 𝜆)𝐹(𝑦⃗).

(9)
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By showing a single counter example to this inequality, we demonstrated that the problem
is non-convex. This convexity test can be found in the supplementary materials.
In addition to this problem being non-convex for full location with phase optimizations,
the computation of the gradient of our objective, which must be estimated by finite differences, is
unreliable due to the mesh grid discretization of the electric field.
Due to the non-convexity of our problem and the unreliability of the gradient, we chose to
customize the pattern search method, a gradient free, direct search optimization strategy for this
study37. This approach allows for a broader search of the parameter space, to help avoid falling
into a local minimum. Each time the algorithm finds a better solution, the parameter step size is
increased. Conversely, if no better point is found, the step size is decreased. The pattern search
method was implemented using a custom MATLAB function that minimized our objective within
certain bounds with a given starting point. Due to the uniqueness of our problem in determining
IMT treatment parameters, a custom algorithm was developed. Within the algorithm, once the
locations of the electrodes are selected for a given iteration, we made use of superposition of
electric field from each electrode to optimize for its phase of the stimulation voltage. Such
superposition of the electric field allows us to calculate the electric field once only and repeatedly
use it during the voltage phase optimization. To avoid bias of user inputted starting points,
parameter starting points were determined using 2n random samples of parameter space, and to
improve convergence rate, the objective function was evaluated for those 2n samples, and the
parameters resulting in the best objective were used as the starting point38-39. The overall pipeline
of the optimization algorithm begins with the creation of the COMSOL model, with manual input
of tumor volume (either simple geometry or any irregular shape) and tissue dielectric and
conductivity properties, choice of optimization parameters and bounds (location, relative phase
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shift), choice of objective function (no tissue sparing or tissue sparing), and lastly, the pattern
search optimization which evaluated the objective function based on the COMSOL simulations.

D. Robustness of the Pattern Search Algorithm
The robustness of our pattern search algorithm was evaluated for the 5 electrode 3 contact
full phase optimization (14 variables relative to the top contact of electrode 1). Each of the 14
electrode contacts was assigned a random relative phase shift starting point for the optimization.
The pattern search optimization was repeated for 50 more random starting points to evaluate the
convergence of the pattern search algorithm to the optimal solution. The algorithm was considered
converged to an optimal solution37-39 when the change in parameter value (step size) for an iteration
was less than 1% of the range of the parameter (when phase shift parameter changes reached 0.063
-A

radians (+//), and location changes were below 0.3 mm)38-39. The starting parameters, optimal
parameters, starting objective value, optimal objective value and number of iterations were all
considered for each run of the algorithm.

E. Spherical Tumor Optimal Configurations, Phase Shift and Maximum Treatable Tumor Size
The maximum treatable tumor size for each number of electrodes was estimated by using
the optimal geometric and phase configurations found by our algorithm. Since the optimal location
within each configuration is dependent on the tumor size, the specific electrode locations were
optimized for a range of tumor sizes. The electric field distributions for these optimal locations
were then evaluated for the percentage of tumor volume covered by 95% of the prescription field
(1 V/cm). We defined the maximum treatable tumor size as the spherical diameter with at least
95% of the volume covered by a 95% time average field “dose”. This threshold was adopted from
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the minimum standard for radiotherapy treatment planning40-41. We began by optimizing the
location and phase shifts of up to 7 electrode systems with single contact electrodes. Once we
understood this, we optimized the configuration for electrodes with 2 and then 3 contacts.

F. Tissue Sparing
The optimization algorithm was applied to a tissue sparing example, where a 2.5 cm
diameter spherical tumor was intersected by a 1.8 cm diameter cylindrical organ to be spared,
creating a non-spherical target volume. The weighing factor in the objective G was set to w = 0.1
in this example. A full location and phase shift optimization of a 5 electrode single contact model
was implemented in this investigation.

Results

A. Sensitivity Analysis
A sensitivity analysis was performed to investigate frequency, conductivity and dielectric
constant effects on the electric field. There was less than 1% change in impedance over the range
of 0-350 kHz relative to the 200 kHz impedance value. The relative difference in temporal average
electric field maps was found to be less than 1% for frequencies ranging from 0 to 500 kHz relative
to the 200 kHz reference field map. The relative difference in electric field maps was found to be
less than 1% for conductivities ranging from 0.2 to 0.3 S/m relative to the 0.24 S/m reference field
map, and dielectric constants between 500 and 4000 had equivalent field maps within 1%
difference relative to the 2000 dielectric reference field map.
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B. Robustness of the Pattern Search Algorithm
Our custom pattern search algorithm was robust in finding a global minimum of our
optimization problem for the most complex case of full 14 variable phase optimization for the 5
electrode 3 contact model. For the 50 random starting parameter points, the optimization
converged to a global optimum 45 times. The start and end objective values for all 50 runs are
plotted in Fig. 2. Due to the large number of local minima and many equivalent global minima
(due to symmetry) in our problem, and the uncertainty in the objective function value (due to the
discretization of the electric field), the algorithm was considered successful in finding a global
minima if the same objective value was reached to within a certain tolerance.

C. Spherical Tumor Optimal Configurations, Phase Shift and Maximum Treatable Tumor Size

Single contact electrodes:
Beginning with single contact electrodes and a spherical tumor model, we were able to use
our optimization algorithm to find the configurations and relative phase shifts that resulted in the
largest and most uniform electric field coverage over time. We then compared these optimal results
to the field coverage when stimulating 2 V amplitude waveforms or ground electrodes were used,
with no phase shifting.
The optimization of the 2 electrode model was completed in terms of the separation, and
relative phase shift. The result was as expected, with maximally separated waveforms, with
electrode 2 phase shifted 𝜋 radians from electrode 1. We found that for the 2 electrode system, the
maximum tumor diameter it can cover is 1.2 cm, with electrodes placed at r = 4 mm from the
centre. The temporal average electric field map of the optimal configuration is found in Fig. 3, as
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well as the corresponding field animation over time. This result matched the expected solution of
completely out of phase sine waves, to create the maximum electric potential difference (hence
maximum electric field) between electrodes.
We found that for a 3 electrode system, the maximum tumor diameter it can treat is 1.7 cm.
Using maximum tumor size of 1.7 cm diameter, the optimal configuration found from our
optimization was equally spaced input waveforms with phase shifts of 2𝜋/3 and 4𝜋/3 radians
relative to electrode 1. The optimal geometrical configuration was with electrodes placed
equidistant from the centre, and each other. For this 1.7 cm diameter tumor volume, the optimal
distance from the centre was 6 mm. As can be seen in Fig. 3(a(ii))’s corresponding animation,
these parameters lead to an electric field that rotates over time, encompassing the whole tumor
volume, with no stagnant ‘cold spots’. Since we are dealing with a spherically symmetric model,
we expect that electrodes spaced equidistant from each other and from the centre of the sphere
would be optimal. In addition, to create the most homogeneous electric field over time, maximally
separated phase shifted input sine waves would lead to a symmetrically rotating electric field,
which matched the optimization results.
For the 4 electrode model, the optimal configuration was all four electrodes placed
equidistant from each other, with maximally separated input waveforms (phase shifts of 0.5𝜋, 𝜋,
1.5𝜋 relative to electrode 1) to create a symmetrically rotating electric field. We found that for a 4
electrode system, the maximum tumor diameter that can be treated is 2.1 cm, for which the optimal
distance from the centre for each electrode was 7.5 mm.
Using a 5 electrode system, the maximum tumor diameter that can be treated is 2.5 cm with
2 V input waveforms. The optimal solution for this case was an electrode placed in the centre, with
4 equally spaced surrounding electrodes. The phase shifts relative to the centre electrode were
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0.5𝜋, 1.5 𝜋, 0.5𝜋, 1.5𝜋 respectively. For a 2.5 cm diameter tumor, the optimal distance from the
centre was 11 mm. Field maps and animations of optimal solutions for both 4 and 5 electrode
models can be found in Fig. 3(a). For the 5 electrode model, we compared the optimal results to
the non-optimized configuration with no use of phase shifting (Fig. 3(b)). Since the electric field
varied within the tumor volume, a cumulative electric field volume histogram (EVH) 6,9 was used
to summarize the tumor coverage. We plotted the absolute tumor volume versus electric field
strength in the EVH, indicating the minimum electric field strength that covers a certain volume
of the tumor (Fig. 3(c)). For the 5 electrode configuration when no phase shifting is used, less than
20% of a 2.5 cm diameter tumor volume is covered by 1 V/cm, but for the optimized phase shifting
case, 95% of the tumor volume is covered. This large tumor coverage increase can be observed
when introducing phase shift to models with any number of electrodes.
Our methods were extended to investigate the optimal configurations and phase settings
for 6 and 7 electrode models. For 6 electrodes, up to 2.94 cm diameter tumors can be covered using
2 V input waveforms with the optimal location of each electrode (𝑟, 𝜃) in mm and radians of (0,0),
(13.75, 0), (13, 0.413𝜋), (11.5, 0.850𝜋), (14.75, 1.2 𝜋), (11.5, 1.588𝜋). The corresponding optimal
phase shifts were 0, 0.618𝜋, 1.460𝜋, 0.372𝜋, 0.938𝜋, and 1.603𝜋 radians. Next for 7 electrodes,
up to 3.34 cm diameter tumors can be covered with a configuration of one central electrode, with
6 equally spaced surrounding electrodes at 13.2 mm from the centre. The optimal phase shifts of
the surrounding electrodes alternate between 0.550𝜋 and 1.436𝜋, similar to the 5 electrode
configuration. By using the optimal configurations found above, the maximum treatable tumor
size (i.e., that with 95% coverage at 95% of the 1 V/cm prescription field) can be determined for
each number of electrodes with 2 V and 4 V input waveforms (Fig. 4).
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Multi-Contact Electrodes:
We further applied our optimization methods to multi-contact electrode models, with 2 or
3 contacts per electrode. The phase shift parameters of each additional contact were added to the
optimization. Starting with a dual contact, 5 electrode model, the optimal configuration is equally
spaced electrodes around a central electrode with phase shifts of the top contacts of 0, 0.6𝜋, 1.4 𝜋,
0.6𝜋, 1.4𝜋, and the bottom contacts 0, 0.4𝜋, 1.6 𝜋, 0.4𝜋, 1.6𝜋, relative to the top centre electrode.
When increasing the number of contacts to 2, our algorithm found an improvement in the objective
function value when separating the phase of the top and bottom contact on an electrode. Compared
to the optimal single contact configuration (0.5𝜋, 1.5𝜋, 0.5𝜋, 1.5𝜋), the top contacts were shifted
by +0.1𝜋, −0.1 𝜋, +0.1𝜋, −0.1𝜋, and the bottom contacts were shifted by −0.1𝜋, +0.1 𝜋, −0.1𝜋,
+0.1𝜋 (Fig. 5).
Our algorithm was further applied to the 5 electrode, 3 contact model, where optimal phase
shifts of contacts were 0, 0.37𝜋, 1.63𝜋, 0.37𝜋, 1.63𝜋 for top contacts, 0.10𝜋, 0.51𝜋, 1.58𝜋, 0.51𝜋,
1.58𝜋 for middle contacts and 0.40𝜋, 0.80𝜋, 1.35𝜋, 0.80𝜋, 1.35𝜋 for bottom contacts, relative to
the top centre contact. By adding a third contact to each electrode the objective was further
improved, and each contact on an electrode had separated phase shift (Fig. 5). For single contact
electrodes the electric field vectors rotate in cross sectional planes perpendicular to the electrode
length. The addition of multiple contacts per electrode results in electric fields that vary in all three
dimensions over time (Fig. 6). These additional contact phase parameters increase the flexibility
of field shaping to cover any tumor shape and result in electric field vector rotation in three
dimensions.
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D. Tissue Sparing
Our algorithm was applied to the tissue sparing example, where optimal electrode
placements (𝑟, 𝜃) were found to be (0,0), (11,0.37𝜋), (9,0.75𝜋), (9,1.25𝜋), and (11,1.63𝜋). Optimal
phase shifts were 0, 0.10𝜋, 1.55𝜋, 0.45𝜋, and 1.9𝜋 radians. The input voltage required to ensure
95% of the tumor volume was covered by 95% of 1 V/cm was 2.4 V. The time average electric
field map of the optimized configuration and corresponding EVH (Fig. 7) highlight the coverage
of the tumor volume with 1 V/cm electric field, while minimizing the field to the spared tissue.

Discussion

We have demonstrated that the problem of determining IMT treatment parameters can be
cast as a mathematical optimization problem. Based on our results, it is clear that the use of relative
phase shifts in the programming of electrode contacts allows for the custom design of location and
time dependent electric vector fields that markedly enhance tumor coverage compared to nonphase shift settings (Fig. 3,6). By optimizing these parameters in addition to the electrode
geometrical configuration and specific locations, we were able to maximize therapeutic field
coverage for spherical tumors up to 5.5 cm diameter, and incorporate tissue sparing.
From the optimization results presented in Results section C. and Fig. 3 we have learned
that for 2 to 4 electrodes, it is optimal to place electrodes equidistant from each other, and the
centre, with equally spaced relative phase shifts. For 5 electrodes, with the increase in treatable
tumor size, it becomes optimal to place an electrode in the centre, with 4 equally spaced
surrounding electrodes. In general, the uniform distribution of electrodes within the tumor volume
is the optimal configuration for all models we tested (Fig. 3). Based on this knowledge,
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optimizations could be improved by starting with electrodes uniformly distributed and optimizing
the distance from the centre and phase configurations for specific tumors.
By increasing the number of electrodes used, the maximum treatable spherical tumor
diameter is increased from < 1 cm for a single stimulating electrode to 1.2 cm, 1.7 cm, 2.1 cm, 2.5
cm, 2.9 cm and 3.4 cm for 2, 3, 4, 5, 6 and 7 electrodes respectively for a 2 V amplitude input
waveform (Fig. 4). By increasing the input voltage amplitude to 4 V, the treatable tumor diameter
is increased to 1.9 cm, 2.8 cm, 3.5 cm, 4.1 cm, 4.8 cm and 5.5 cm respectively (Fig. 4). The results
presented for maximum tumor diameter versus number of electrodes (Fig. 4) were fit to the
function 𝑑 = 𝑎√𝑛 + 𝑏, as we expect that with additional electrodes, this relationship will approach
an approximate square root dependence. The reason is as follows: Adding electrodes does not
impact the ability to cover the longitudinal axis of the tumor (electrode length is always sufficient
to cover this axis), but it does change the coverage of the cross-sectional plane of the tumor
volume. Placement and phase shift optimization will spread the voltage gradients between
electrodes spatially, maximizing the electric field coverage. As a result, after optimized for
placement and phase shifts, each electrode will cover a similar area. Therefore, adding an electrode
will increase the coverage area approximately linearly. Since the target coverage cross-sectional
area varies with the square root of target radius (or diameter), we concluded that the target diameter
coverage would vary with the square root of the number of electrodes. Up to the small range of 7
electrodes, the maximally covered tumor diameter almost appears to be linearly dependent on the
number of electrodes.
In contrast to the additive effects of radioisotopes in brachytherapy, electric fields produced
from multiple sources follow vector addition, leading to possible increased or decreased electric
field strengths. The field cancellation feature can be exploited in tissue sparing situations. Hence,
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finding the locations and phase shifts to maintain sufficient field coverage within the tumor
become increasingly complex and unintuitive with each additional electrode and the inclusion of
critical structures. Such relationships will be further investigated in future studies. Incorporating
tissue sparing into the objective function resulted in the tumor volume being covered by the desired
1 V/cm electric field, while minimizing the field delivered to an intersecting sensitive structure
(Fig. 7, Results D.). The configuration and phase setting rules presented in this study (Fig. 3,
Results C.) were found to apply to frequencies up to 500 kHz, tumor conductivities between 0.2
and 0.3 S/m, and tumor dielectrics between 500 and 4000 (Results A.).
These results provide a set of rules as initial number, configurations and parameters for
patient specific IMT treatment planning, where the size of tumor will be used to determine the
number of electrodes required to cover that volume. If the patient tumor is approximately spherical,
such as diffuse intrinsic pontine gliomas42, the configurations and phase settings outlined here for
2-7 electrodes could be used with distance from centre optimization. If the patient tumor shape is
irregular, the configurations and settings could be used as a starting point for a full location and
phase optimization. The optimization methods and results presented here will be validated by
applying our methods to in vitro, in vivo and in human brain phantom experiments in the future.
This phase shifting approach to temporal electric field delivery maximizes the size of
tumors that are possible to treat, while minimizing the number of electrodes. In addition, by
incorporating multiple individually programmable contacts on each electrode, we were able to
further improve the field coverage, and field shaping. Being able to control and optimize the
distribution of the electric field produced, these methods could be further applied to irregularly
shaped patient specific tumor contours in the future. Multiple contacts on each electrode increase
the flexibility of our model, to adapt the electric fields to any tumor shape. Our objective function
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was also updated to incorporate tissue sparing and could be further modified to include tumor
tissue inhomogeneity weighting terms, or adding a penalty term that would minimize the amount
of power a configuration would require. In addition to increasing the magnitude of the temporal
field coverage, incorporating relative phase shifts results in the electric field vector continuously
changing direction. It has yet to be determined whether changing the direction of the electric field
facilitates tumor cell death, but our method provides the capability to examine this hypothesis by
designing experiments to investigate rotating field effects on the dielectrophoretic force
hypothesis14,43-45, mitotic spindle microtubule interaction hypothesis14,43-45, and cell membrane
effects46. The application of our algorithm to design an in vitro experiment to investigate rotating
fields can be found in the appendix. Such data could play a substantial role in informing future
IMT advances.
Limitations of this study include the use of equal depth parallel electrodes. In reality,
electrodes could have different insertion angles with different insertion depths. In future studies,
this could be rectified by incorporating electrode angle and depth into the optimization simulations
and by varying the input voltage amplitudes along the contacts of each electrode to compensate
for differing separations along the electrode length. The tumor models investigated in this study
utilized scalar conductivity, and while the sensitivity analysis showed anisotropies between 0.2
and 0.3 S/m would have minimal effect (<1%) on the electric field (Results A.), anisotropies
outside this range could impact the distribution. Future studies will include patient-specific
planning with anisotropies. Another limitation is that implanted electrodes result in a steep field
gradient near the electrode surface, and while our optimization alleviated this and maximized the
coverage, inhomogeneous fields remained as in brachytherapy. Similar to the comparison between
external beam radiotherapy and brachytherapy, external electric field delivery could create more
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homogeneous fields, but the internal delivery has its benefits, such as reaching tumors in the deep
brain and brainstem with more sparing capability for organs at risk, and providing a continuous
treatment with no devices directly attached to the scalp which requires a shaved head. Heating
mechanisms associated with implanted electrodes were also considered, to ensure that implanting
electrodes at IMT voltages (2 V - 4 V) and frequency (200 kHz) would not result in adverse tissue
heating or theoretical limitations to clinical implementation. At the low voltages proposed for IMT,
Joule heating would theoretically contribute <0.8°C to tissue directly adjacent the electrode
surface, falling off with distance from the electrode47. At the intermediate frequency of 200 kHz,
heating from dielectric losses are negligible, with the dielectric relaxation time of brain tissue
remaining below the input waveform period, minimizing dielectric losses5,10-11,48. Limitations in
the optimization algorithm pipeline include long computation times and manual input requirements
which will need to be rectified before clinical implementation.
These baseline optimizations were performed on spherical tumor models in order to
determine a set of rules for IMT treatment planning optimization. The optimization methods have
been designed to allow users to input the required tissue electrical properties, import the tumor
volume, choose the field threshold, and perform an optimization to find optimal electrode
programming and placement. The incorporation of multiple separately programmable contacts on
each electrode could allow for the optimization of irregularly shaped tumors to produce unique
field coverage patterns. In addition, our algorithm can incorporate tissue sparing and organs at risk
to minimize field exposure outside of the tumor. Overall, our optimization algorithm could be
applied to any patient specific tumor model, for different electrode designs and optimization
parameters.
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Conclusions

Our methods for temporally optimizing the electric field coverage with respect to relative
phase shift programming, geometrical configurations, electrode and contact numbers for IMT are
the first of their kind and have the adaptability to be able to incorporate a wider range of
optimization parameters and tumor shapes/types in future investigations. This study has provided
a baseline investigation and presentation of an optimization method for multi-electrode IMT,
considering spherical tumor models. Current limitations include the use of parallel electrodes of
equal depth, and the electric field inhomogeneities inherent to internal electrode placement.
Overall, we have demonstrated the capability to optimize electrode placement and stimulation
settings using methods developed specifically for IMT. These baseline tumor electrode
configurations and phase setting rules are a critical first step in developing a patient specific
treatment planning system for IMT.

Appendix

Proposed In Vitro Experiment
Our optimization algorithm was used to design a multi-electrode in vitro experiment to test
the effects of electric field rotation. Four electrodes of 0.8 mm radius in a 1.75 cm radius in vitro
dish were simulated in COMSOL. We first utilized our optimization algorithm to determine the 4
electrode geometry and input voltage amplitude of each electrode that results in a 1 V/cm
amplitude rotating electric field within a 0.5 cm × 0.5 cm viewing window. The updated objective
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∑> N𝐸> − 𝐸<56= O is the square difference of the average temporal electric field

and the prescription 1 V/cm field.
The closer the majority of voxels are to 1 V/cm, the lower the objective value. Since we
are looking at a 4 electrode rotating model, phase shifts for this optimization were set to 0, 0.5𝜋,
𝜋, 1.5𝜋 radians, and electrodes were equally spaced. The optimization algorithm was used to find
the optimal input voltage and distance from the centre of the electrodes, to ensure a continuous 1
V/cm is applied in the viewing window. Next, our optimization algorithm was used to determine
the placement of electrodes and amplitude of input square waves that result in a 1 V/cm nonrotating electric field.
We found that equally spaced electrodes placed 1.5 cm from the centre with input voltage
amplitudes of 5.17 V led to a continuously rotating electric field of 1.00±0.01 V/cm temporal
average within the viewing window. The non-rotating electric field optimization resulted in all 4
electrodes placed 1.27 cm from the centre at angles of ±0.488 and ±2.663 radians with alternating
input voltages of 5.17 V and 0 V. This led to a time average electric field of 1.00±0.03 V/cm (Fig.
8).
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Figures

Fig. 1. Geometry of a 5 electrode, 3 contact tumor model (grey) created in COMSOL. Total of 15 contacts,
each with separately programmable input waveforms highlighted by different colours. The tumor is
surrounded by normal tissue.
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Fig. 2. Objective function value for starting random parameters and final minimized objective value for
50 runs with different random starting parameters.
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Fig. 3. Average temporal electric field maps and corresponding animations of field coverage over time for
(a) 2, 3, 4, and 5 optimally placed electrodes in cross sections of corresponding maximum tumor volumes
(black circle). (b) 5 electrode configuration with no phase shifting (centre, upper left, bottom right: 2 V
amplitude stimulating electrodes, upper right and bottom left: 0 V ground electrodes). 2, 3, and 4 electrode
figures with no phase shifting can be found in the supplementary materials (Fig. S-1). (c) Electric field
volume histogram of the tumor volume (cm3) receiving at least a certain temporal average electric field
value (V/cm) for both optimized phase shift and no phase shift cases.
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Fig. 4. Maximum treatable tumor diameter (95% coverage of 95% of prescription 1 V/cm) for 2, 3, 4, 5, 6
and 7 single contact electrodes at both 2 V and 4 V input sine wave amplitudes. The data was fit to a
function of 𝑑 = 𝑎√𝑛 + 𝑏, where 𝑑 is the tumor diameter, 𝑛 is the number of electrodes, and 𝑎 and 𝑏 are fit
parameters. With 7 electrodes, at 4 V, with optimal location and phase shift, tumors up to 5.5 cm diameter
could be treated.
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Fig. 5. Input voltage sine waves of optimal phase shift configurations with corresponding contact
geometries for (a) single contact, (b) 2 contacts, and (c) 3 contacts. Two periods of the waveforms are
shown. Contacts of the same colour have the same phase shift, contacts of different hue of the same colour
differ slightly in phase shift and different colours differ maximally in phase shift.
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Fig. 6. Animations of 1 V/cm isosurface coverage (red) of tumor volume (cyan) over time. Normalized
electric field vectors show the field direction over time for both (a) single contact, 5 electrode and (b) 3contact, 5 electrode models.
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Fig. 7. (a) Average temporal electric field maps and corresponding animations of field coverage over time
for a 5 electrode tissue sparing example with optimally placed and programmed electrodes. (b) Electric
field volume histogram of the percent tumor volume and spared tissue receiving at least a certain temporal
average electric field value (V/cm).

Fig. 8. Time average electric field magnitude (V/cm) for (a) rotating electric field and (b) non-rotating
electric field. (Animation includes field vectors).

